XML 18 R8.htm IDEA: XBRL DOCUMENT v3.22.4
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
USD ($)
Jun. 30, 2022
USD ($)
Jun. 30, 2021
USD ($)
Cash flows from operating activities:      
Net cash provided by operating activities   $ 225,424 $ 257,120
Cash flows from investing activities:      
Proceeds from sale of property and equipment   1 28
Purchases of property and equipment   (3,793) (3,024)
Purchases of equity securities   (55,273) (14,192)
Purchases of available-for-sale debt securities   (134,899) (237,353)
Proceeds from sales of equity securities $ 2,760 17,692 5,165
Proceeds from sales of available-for-sale debt securities   19,534 60,978
Proceeds from sales of investment real estate   0 2,591
Maturities of available-for-sale debt securities   33,683 53,313
Net cash provided by (used in) investing activities   (123,055) (132,494)
Cash flows from financing activities:      
Debt issuance costs paid   (131) 0
Preferred stock dividend   (5) (5)
Common stock dividend   (9,974) (10,101)
Purchase of treasury stock   (7,381) (245)
Payments related to tax withholding for share-based compensation   (209) (784)
Repayment of debt   (735) (735)
Net cash provided by (used in) financing activities   (18,435) (11,870)
Cash and cash equivalents and restricted cash and cash equivalents:      
Net increase (decrease) during the period   83,934 112,756
Balance, beginning of period   253,143 179,871
Balance, end of period 337,077 337,077 292,627
Cash and cash equivalents, and restricted cash and cash equivalents within the Consolidated Balance Sheets      
Cash and cash equivalents 316,952 316,952  
Restricted cash and cash equivalents 20,125 [1] 20,125 [1]  
Total cash and cash equivalents and restricted cash and cash equivalents $ 337,077 $ 337,077 $ 292,627
[1] See “—Note 5 (Insurance Operations)” for a discussion of the nature of the restrictions for restricted cash and cash equivalents.